Publications by authors named "Marco Bolchini"

Claim this Profile
A
A possible atypical presentation of Tolosa-Hunt syndrome, a case report.
Marco Bolchini, Giulia Campana, Matteo Cortinovis, Paola Zavarise, Giorgio Dalla Volta

Neurol Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study).
Gloria Vaghi, Luigi Francesco Iannone, Michele Corrado, Federico De Santis, Marina Romozzi, Marco Bolchini

Ther Adv Neurol Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CGRP monoclonal antibodies, migraine and mood disorders: an observational study.
Marco Bolchini, Giulia Ceccardi, Francesca Schiano di Cola, Michele Di Pasquale, Renata Rao

Neurol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical presentation of herpes zoster with cranial neuralgia and nodular skin lesions, a case report.
Marco Bolchini, Matteo Cortinovis, Paola Zavarise, Giorgio Dalla Volta

Neurol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous bilateral intracranial-tract internal carotid artery stenting (CAS), a case report.
Lanfroi Graziani, Marco Bolchini, Paola Zavarise, Giorgio Dalla Volta

Acta Neurol Belg· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onabotulinumtoxin-A: Previous Prophylactic Treatment Might Improve Subsequent Anti-CGRP Monoclonal Antibodies Response in Patients with Chronic Migraine.
Giulia Ceccardi, Francesca Schiano di Cola, Salvatore Caratozzolo, Michele Di Pasquale, Marco Bolchini

Toxins (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An observational study on monoclonal antibodies against calcitonin-gene-related peptide and its receptor.
Francesca Schiano di Cola, Marco Bolchini, Giulia Ceccardi, Salvatore Caratozzolo, Paolo Liberini

Eur J Neurol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine Disability and Severity Improvement during Long-Term Treatment with Erenumab.
Marco Bolchini, Francesca Schiano di Cola, Giulia Ceccardi, Salvatore Caratozzolo, Paolo Liberini

Eur Neurol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine Disability Improvement during Treatment with Galcanezumab in Patients with Chronic and High Frequency Episodic Migraine.
Francesca Schiano di Cola, Marco Bolchini, Salvatore Caratozzolo, Giulia Ceccardi, Matteo Cortinovis

Neurol Int· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photophobia and migraine outcome during treatment with galcanezumab.
Francesca Schiano di Cola, Giulia Ceccardi, Marco Bolchini, Salvatore Caratozzolo, Paolo Liberini

Front Neurol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients.
Francesca Schiano di Cola, Salvatore Caratozzolo, Marco Bolchini, Giulia Ceccardi, Matteo Cortinovis

Neurol Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
White Matter Hyperintensities Quantification in Healthy Adults: A Systematic Review and Meta-Analysis.
Luca Melazzini, Paolo Vitali, Emanuele Olivieri, Marco Bolchini, Moreno Zanardo

J Magn Reson Imaging· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis